drugset / Trial / NCT03804749
Study to Evaluate the Tolerance and Pharmacokinetics of Suramin Sodium
Phase 1
Unknown
36 enrolled
First Affiliated Hospital of Zhejiang University
Guangdong Kangda Pharmaceutical Co., Ltd · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled, single-dose with three incremental doses, Phase 1 study to evaluate the tolerance and pharmacokinetics of suramin sodium for injection in Chinese healthy adults.
Timeline
- Start
- 2018-12-19
- Primary completion
- 2019-12-19
- Completion
- 2020-12-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | suramin | Small molecule | 10 mg/kg | — |
| Subject | suramin | Small molecule | 15 mg/kg | — |
| Subject | suramin | Small molecule | 20 mg/kg | — |